SERIALIZATION FEATURED ARTICLES
Serialization – Pharma Faces 2015 Deadline
Pharmaceutical executives are hustling to finalize plans to implement the Drug Quality and Security Act, which became law last November. Although that law was seen as allowing extra time to serialize packaging lines, it actually moves up some deadlines and adds additional requirements that are causing pharmaceutical companies to adjust their serialization strategies and implementation timelines.
SERIALIZATION WHITE PAPERS & CASE STUDIES
The Definitive Guide To Decoding Barcodes
Barcode technologies provide fast reliable data collection to ensure part or product traceability, error-proof assembly processes, and enhance customer service.
A Step-by-Step Guide to Implementing An Effective Track-And-Trace Program
Although a universal standard for pharmaceutical track-and-trace solutions has yet to emerge, the California Board of Pharmacy’s ePedigree requirements are currently driving action in efforts toward implementing serialization to provide supply-chain integrity to the public. At Aphena Pharma Solutions, we have developed a step-by-step process that has helped us establish a very effective track-and-trace program.
SERIALIZATION PRODUCTS & SERVICESMore Serialization Products & Services
LIFE SCIENCE WEBINARS
H.R. 3204 Drug Quality And Security Act
After so many years of struggling with how to comply with the California ePedigree requirement, we now need to know how to comply with the new federal requirement, H.R. 3204. This webinar will review DQSA requirements and timelines.
Top Things To Consider When Evaluating Your Vendor’s Security Of Supply Strategies
The biopharmaceutical industry’s increasingly complex global supply chains, often involving single-source supplier arrangements, are made vulnerable by uncertain financial environments and unpredictable natural disasters.
Successfully Managing The Risks And Challenges Of Orphan Drugs
Orphan drugs, while life changing and in many cases life saving for patients, are fraught with challenges for biotech and pharmaceutical manufacturers. These range from locating the patients and their physician caregivers, to making sure the patients can pay for these therapies, to the overcoming the numerous risk points in moving very expensive and in most cases temperature controlled goods to patients all over the globe. This webinar looks at addressing these issues. The experienced speakers will guide you through the salient points and considerations when dealing with these challenges.
The Cost of Failure In Pharma Development: A Risk for Everyone
Predicting potential problems serves no purpose if it is not accompanied by adequate corrective actions or mitigation strategies to address them. This webinar will also discuss risk mitigation options for both early and late stage development programs.